Form 8-K Adamas Pharmaceuticals For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Adamas Pharmaceuticals (ADMS) Misses Q3 EPS by 13c
November 4, 2014 4:58 PM ESTAdamas Pharmaceuticals (NASDAQ: ADMS) reported Q3 EPS of ($0.57), $0.13 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Adamas Pharmaceuticals (ADMS) click here.
... More


